Edith Mitchell, M.D.
Clinical Professor of Medicine and Medical OncologyEdith Peterson Mitchell, MD, is Clinical Professor of Medicine and Medical Oncology and Program Leader in Gastrointestinal Oncology at Thomas Jefferson University. In addition, she holds the positions of Associate Director of Diversity Programs for the Kimmel Cancer Center at Jefferson and Director of the Kimmel Cancer Center to Eliminate Cancer Disparities. Dr. Mitchell received a B.S. in biochemistry "with distinction" from Tennessee State University and her medical degree from the Medical College of Virginia in Richmond. In 1973, while attending medical school, Dr. Mitc...
Source: PHRMA - March 30, 2015 Category: Pharmaceuticals Authors: Ali Source Type: news
Edith Mitchell
Clinical Professor of Medicine and Medical OncologyEdith Peterson Mitchell, MD, is Clinical Professor of Medicine and Medical Oncology and Program Leader in Gastrointestinal Oncology at Thomas Jefferson University. In addition, she holds the positions of Associate Director of Diversity Programs for the Kimmel Cancer Center at Jefferson and Director of the Kimmel Cancer Center to Eliminate Cancer Disparities. Dr. Mitchell received a B.S. in biochemistry "with distinction" from Tennessee State University and her medical degree from the Medical College of Virginia in Richmond. In 1973, while attending medical school, Dr. Mitc...
Source: PHRMA - March 30, 2015 Category: Pharmaceuticals Authors: Ali Source Type: news
Joshua Cohen - Dr/patient relationship
A doctor-patient relationship represents a collaboration, a shared commitment by both doctor and patient to work towards a common goal of therapeutic success. The importance of this mutual determination cannot be understated as treatment efficacy relies on both parties as neither can be successful in isolation.
As a headache specialist, I find this message driven home to me on a daily basis. When I work out a treatment plan with a patient, it is a conversation, not a lecture. We determine together what is realistic for the patient – goals of care, ability to take medication, tolerance for side effects, capacity t...
Source: PHRMA - March 30, 2015 Category: Pharmaceuticals Authors: Ali Source Type: news
Joshua Cohen, M.D.
NeurologistJoshua M. Cohen, MD, MPH is Director of Education at Mount Sinai Continuum Hospitals, Director of the Headache Fellowship Program at the Headache Institute and Adolescent Headache Center, an attending neurologist at Mount Sinai Roosevelt Hospital, and an assistant professor of neurology at the Icahn School of Medicine at Mount Sinai. He is Board certified in Neurology and Headache Medicine. He is a leader in organized medicine on the national, state, and local level, currently serving as President of the New York County Medical Society and on the governing Council of the Medical Society of the State of New Yor...
Source: PHRMA - March 30, 2015 Category: Pharmaceuticals Authors: Ali Source Type: news
Joshua Cohen
NeurologistJoshua M. Cohen, MD, MPH is Director of Education at Mount Sinai Continuum Hospitals, Director of the Headache Fellowship Program at the Headache Institute and Adolescent Headache Center, an attending neurologist at Mount Sinai Roosevelt Hospital, and an assistant professor of neurology at the Icahn School of Medicine at Mount Sinai. He is Board certified in Neurology and Headache Medicine. He is a leader in organized medicine on the national, state, and local level, currently serving as President of the New York County Medical Society and on the governing Council of the Medical Society of the State of New Yor...
Source: PHRMA - March 30, 2015 Category: Pharmaceuticals Authors: Ali Source Type: news
Bill Chin on Dr/patient relationships
When we look at the relationship between doctor and the patient, there is one theme that is constant: putting the patient first. The responsibility stands squarely on the shoulders of the physician from the onset to help make the patient feel comfortable and prepared to engage in an open and honest dialogue to help formulate a treatment plan.
In many ways, the special relationship is a moral one with the patient putting their faith in the hands of another individual in the hope of a positive outcome.
When meeting with a patient, it’s important for physicians to remember they’re speaking with a person afflicted with a ...
Source: PHRMA - March 27, 2015 Category: Pharmaceuticals Authors: Ali Source Type: news
Edmond B. Cabbabe
The doctor /patient relationship is built on mutual respect, utmost trust, and dedication of the parties involved. This relationship allows both parties to engage in a frank and open professional interaction that best serves the patient health care needs. Such a relationship must not be affected by an outside pressure, on either side, to force a different choice of care nor be affected by any monetary gain or loss.
The proliferation of managed care, Medicare advantage plans, hospital ownership of practicing physicians, and other care delivery models has weakened this special relationship. From withholding or delaying care ...
Source: PHRMA - March 27, 2015 Category: Pharmaceuticals Authors: Ali Source Type: news
#MedicareMonday: Helping Hypertensive Patients Live Healthier Lives
Hypertension, or high blood pressure, is a chronic condition affecting an estimated 70 million people in the United States. Unfortunately, just 52 percent of these individuals have their high blood pressure under control. Many people don’t realize taking their medicines as prescribed can help keep this chronic condition in check – and save money – for both individuals and the health care system overall.
As we’ve been covering in recent weeks, programs like Medicare Part D help individuals access needed medicines, and adhering to a prescription regimen can help avoid hospital visits and other costly care. A recent...
Source: PHRMA - March 2, 2015 Category: Pharmaceuticals Authors: Emily Source Type: news
Test
[<a href="//storify.com/emilyCM/rare-disease-tweetchat" target="_blank">View the story "#abcDrBchat on Rare Disease with NORD and Dr. Richard Besser of ABC News " on Storify</a>] (Source: PHRMA)
Source: PHRMA - February 25, 2015 Category: Pharmaceuticals Authors: Emily Source Type: news
Eileen Cannon
Company: PhRMA (Source: PHRMA)
Source: PHRMA - February 18, 2015 Category: Pharmaceuticals Authors: Emily Source Type: news
Karie Youngdahl on Measles
In 1713, Cotton Mather, a prominent Boston minister who would bring the practice of smallpox variolation to the colonies, watched helplessly as measles devastated his family. On October 18 of that year he wrote in his diary, “The Measles coming into the Town, it is likely to be a Time of Sickness, and much Trouble in the Families of the Neighbourhood.” That day his eldest son became ill. Two daughters developed measles over the next few days. However, in the midst of this “heavy Calamity,” there was joy: his wife gave birth to twins Eleazar and Martha.
But in quick succession Mather’s wife, three more daughters, ...
Source: PHRMA - February 13, 2015 Category: Pharmaceuticals Authors: Emily Source Type: news
Karie Youngdahl
DirectorKarie Youngdahl is the director of the award-wining History of Vaccines project, found online at www.historyofvaccines.org. The site offers historical and contemporary information about vaccines and vaccine-preventable diseases with the aim of exploring the impact vaccines have had on human health. The History of Vaccines is a project of The College of Physicians of Philadelphia, the oldest professional medical society in the United States.
Youngdahl is a graduate of Stanford University. Before launching HistoryofVaccines.org in 2010, she worked as a writer and editor in educational and biomedical publishing.
h...
Source: PHRMA - February 13, 2015 Category: Pharmaceuticals Authors: Emily Source Type: news
What can the lessons of measles teach us about the importance of vaccines?
Karie Youngdahl on Measles
Submitted by Emily on Fri, 02/13/2015 - 11:47
In 1713, Cotton Mather, a prominent Boston minister who would bring the practice of smallpox variolation to the colonies, watched helplessly as measles devastated his family. On October 18 of that year he wrote in his diary, “The Measles coming into the Town, it is likely to be a Time of Sickness, and much Trouble in the Families of the Neighbourhood.” That day his eldest son became ill. Two daughters developed measles over the next few days.
Share
Email
Print
...
Source: PHRMA - February 11, 2015 Category: Pharmaceuticals Authors: Emily Source Type: news
Thomas J. Berger, PH.D. on measles
It comes to no surprise that the recent outbreak of more than 100 cases (at this writing) of measles in the nation opened up contentious debate over vaccinations, which in turn , has a profound impact on public health. Though measles were declared no longer endemic in the United States more than a decade ago, it has not been eradicated. As long as measles exist around the globe, still common in some countries in Europe, Asia, the Pacific, and Africa, the threat of its introduction by people outside of the country will continue to remain. The outbreak brings to light that immunization is in itself a public health issue, and...
Source: PHRMA - February 11, 2015 Category: Pharmaceuticals Authors: Emily Source Type: news
Thomas J. Berger, PH.D.
Executive DirectorDr. Tom Berger is a Life Member of Vietnam Veterans of America (VVA) and founding member of VVA Chapter 317 in Kansas City, Missouri. Dr. Berger served as a Navy Corpsman with the 3rd Marine Corps Division in Vietnam, 1966-68. Following his military service and upon the subsequent completion of his postdoctoral studies, he held faculty, research and administrative appointments at the University of Kansas in Lawrence, the State University System of Florida in Tallahassee, and the University of Missouri-Columbia, as well as program administrator positions with the Illinois Easter Seal Society and United Cer...
Source: PHRMA - February 11, 2015 Category: Pharmaceuticals Authors: Emily Source Type: news
